Previous 10 | Next 10 |
SWAV's approval to distribute products in China to significantly boost revenue growth in the coming quarters. SWAV posted strong Q1 2022 results with a solid FY22 outlook. The company is overvalued at current price level despite taking into account the robust growth rate. I as...
Baxter’s 8.7% 5-yr return on invested capital, ROIC, is quite a bit below its peers. TTM ROIC of 6.1% is about half the Industry ETF avg of 11.1%. Long-term debt ballooned from $5.8 billion at the end of 2020 to $17.1 billion as of March 2022. Goodwill assets also jumped t...
As companies adjust to inflation, rising interest rates, and a likely economic slowdown, investors are struggling to compute future earnings and the impact on stock valuations. Broadening the sources of stability can help diversify risk and return potential. Geopolitical risk and ...
In the midst of a bear market, smart investors are looking for a bright future for investments that have taken an uncharacteristic recent loss. You don't have to spend too much time researching to find many candidates. But finding investments that can withstand a prolonged challenging marke...
Why the economy, practically speaking, may already be in recession. Why defensive sectors may be worth a closer look in the current environment. Market sentiment might be bearish, but that doesn't mean there aren't opportunities. Aggressive moves by central banks...
The first five months of the year marked the worst start for the S&P 500 since 1970 ― and the sixth worst back to 1928. Stock valuations have come down, but company earnings remain solid. Earnings will slow, but 20% is hard to imagine, even in a recession. For fur...
Today, we put medical device maker Vicarious Surgical Inc. in the spotlight for the first time. The company is looking to revolutionize the minimally invasive surgical space by building a better mousetrap for the surgical community. An investment analysis follows in the paragraphs...
In spite of half of our FMP's four building blocks trading in distress-mode, the portfolio/investment strategy is working just fine. Although stocks are no longer expensive, the economy is looking so fragile, posing a great deal of risk for further decline. This year's lead invest...
iShares U.S. Medical Devices ETF (IHI) - $0.0481. 30-Day SEC Yield of 0.36% as of April. 29. Payable Jun 15; for shareholders of record Jun 10; ex-div Jun 09. For further details see: iShares U.S. Medical Devices ETF declares quarterly distribution of $0.0481
How similar will the next three or five years look from the years that immediately preceded the pandemic? And what are the implications for us as global equity investors? We don’t expect anything like the hyperinflation and stagflation we experienced in the 1970s; our outlook s...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Medical Devices Company Name:
IHI Stock Symbol:
NYSE Market:
2024-07-12 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-21 21:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...